Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02914483 · ClinicalTrials.gov registry record · NA

Women's Heart Attack Research Program: Stress Ancillary Study

A NA study of Myocardial Infarction, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
14
Study locations

NCT02914483 is a NA study of Myocardial Infarction that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 200 participants, below the 4,679-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (96% lower). The trial reports 14 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02914483, a NA study of Myocardial Infarction, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
14
Study locations

Study Summary

The Women's HARP study is a multi-center study focusing on women with clinical presentation of myocardial infarction (MI). Women will complete stress questionnaires following presentation to the medical center with elevated cardiac enzymes and abnormal electrocardiograms (ECGs). 2 months following MI, participants will be screened for the Stress Ancillary Study and enrolled if an elevated level of perceived stress is reported. After completing baseline assessments, participants will be randomized to Enhanced Usual Care (EUC) or stress management for 8 weeks. Participants will be followed for 6 months.

Conditions Studied

Myocardial Infarction

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL Stress Management
  • DIAGNOSTIC_TEST Actigraph

Study Locations (14)

New York

  • NYU Winthrop - Mineola
  • NYU Langone Medical Center - New York
  • Columbia University Medical Center - New York

Pennsylvania

  • St. Luke's University Health Network - Bethlehem
  • University of Pittsburgh Medical Center - Pittsburgh

California

  • Cedars-Sinai Medical Center - Los Angeles

Florida

  • Univeristy of Florida - Gainesville

Georgia

  • Emory University - Atlanta

Maryland

  • Johns Hopkins Medical Center - Baltimore

New Hampshire

  • Dartmouth-Hitchcock - Lebanon

Ohio

  • Ohio State University Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2016-08-01
Est. Completion 2026-06-30
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02914483

The ClinicalTrials.gov registry entry for NCT02914483 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,679-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (96% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 3 interventions - of which Enhanced Usual Care is the first listed.

NCT02914483 reports 14 study locations spanning 11 distinct geographic areas - top geographies include New York, Pennsylvania, California.

Frequently Asked Questions

What is clinical trial NCT02914483 about?

NCT02914483 is a clinical study titled "Women's Heart Attack Research Program: Stress Ancillary Study". The Women's HARP study is a multi-center study focusing on women with clinical presentation of myocardial infarction (MI). Women will complete stress questionnaires following presentation to the medical center with elevated cardiac enzymes and abnormal electrocardiograms (ECGs). 2 months following M...

What is the current status of trial NCT02914483?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2016-08-01. Estimated completion is 2026-06-30.

What conditions does trial NCT02914483 study?

This clinical trial studies the following conditions: Myocardial Infarction.

What interventions are being tested in trial NCT02914483?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Stress Management (BEHAVIORAL), Actigraph (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT02914483?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02914483 being conducted?

This trial has 14 study locations across California, Florida, Georgia, Maryland, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myocardial Infarction

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.